9 results match your criteria: "Division of Gastroenterology (Liver Unit). University of Alberta[Affiliation]"
Hepatol Commun
August 2024
Division of Gastroenterology (Liver Unit). University of Alberta, Edmonton, Alberta, Canada.
Background: Alcohol-associated hepatitis (AH) is associated with significant mortality. Model for End-Stage Liver Disease (MELD) score is used to predict short-term mortality and aid in treatment decisions. MELD is frequently updated in the course of AH.
View Article and Find Full Text PDFLiver transplantation (LT) is the definitive treatment for end-stage liver disease. Unfortunately, women are disadvantaged at every stage of the LT process. We conducted a literature review to increase the understanding of this disparity.
View Article and Find Full Text PDFLiver Transpl
June 2022
Karsh Division of Gastroenterology and Comprehensive Transplant Center, Department of Medicine Cedars-Sinai Medical Center Los Angeles CA Department of Medicine University of Maryland Medical Center Baltimore MD 2569 Department of Gastroenterology, Hepatology and Nutrition Cleveland Clinic Cleveland OH Annette C. and Harold C. Simmons Transplant Institute Baylor University Medical CenterBaylor Scott and White Dallas TX Department of Critical Care and Division of Gastroenterology (Liver Unit) University of Alberta Edmonton AB Canada Division of Gastroenterology and Hepatology, Department of Medicine Northwestern University Chicago IL Division of Gastroenterology and Hepatology, Department of Medicine Oregon Health and Sciences University Portland OR Division of Gastroenterology and Hepatology, Department of Medicine University of Colorado School of Medicine Aurora CO Piedmont Transplant Institute Piedmont Healthcare Atlanta GA Division of Gastroenterology and Hepatology, Department of Medicine Hospital of the University of Pennsylvania Philadelphia PA Division of Gastroenterology and Hepatology, Department of Medicine Weill Cornell Medical College New York NY.
Although liver transplantation (LT) yields survival benefit for patients with acute-on-chronic liver failure grade 3 (ACLF-3), knowledge gaps remain regarding risk factors for post-LT mortality. We retrospectively reviewed data from 10 centers in the United States and Canada for patients transplanted between 2018 and 2019 and who required care in the intensive care unit prior to LT. ACLF was identified using the European Association for the Study of the Liver-Chronic Liver Failure (EASL-CLIF) criteria.
View Article and Find Full Text PDFAcute kidney injury (AKI) is a common condition following liver transplantation (LT). It negatively impacts patient outcomes by increasing the chances of developing chronic kidney disease and reducing graft and patient survival rates. Multiple definitions of AKI have been proposed and used throughout the years, with the International Club of Ascites definition being the most widely now used for patients with cirrhosis.
View Article and Find Full Text PDFWatch a video presentation of this article Watch an interview with the author.
View Article and Find Full Text PDFHepatol Commun
October 2019
LiverSafe Clinic, Division of Gastroenterology (Liver Unit) University of Alberta, CEGIIR Edmonton Canada.
Detection of advanced fibrosis in nonalcoholic fatty liver disease (NAFLD) is essential for stratifying patients according to the risk of liver-related morbidity. Noninvasive methods such as vibration-controlled transient elastography (VCTE) and Fibrosis-4 index (FIB-4) have been recommended to identify patients for further assessment. The aim of this study was to assess the potential impact of implementing a "FIB-4 First" strategy to triage patients entering a NAFLD assessment pathway.
View Article and Find Full Text PDFBackground And Aims: Obesity is frequently associated with cirrhosis, and cirrhotic patients may develop simultaneous loss of skeletal muscle and gain of adipose tissue, culminating in the condition of sarcopenic obesity. Additionally, muscle depletion is characterized by both a reduction in muscle size and increased proportion of muscular fat, termed myosteatosis. In this study, we aimed to establish the frequency and clinical significance of sarcopenia, sarcopenic obesity and myosteatosis in cirrhotic patients.
View Article and Find Full Text PDF